Hutch News

Stories tagged 'Public Health Sciences'

Good News at Fred Hutch

Celebrating faculty and staff achievements

June 22, 2017

A new algorithm created by Dr. Philip Bradley and colleagues could aid the development of tools to decode T-cell receptor sequences and, ultimately, improve the diagnosis and treatment of cancers, reported this week in Nature.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

June 16, 2017

Dr. Eduardo Méndez has received a five-year, $2.2 million grant from the National Institutes of Health to develop the first targeted therapy that they hope will be effective for most patients with head and neck cancers.

View story >


Aspirin and its cousins linked to longer survival after colorectal cancer

Large study of preventive drugs for colorectal cancer survivors finds link to decreased mortality — but only for those with certain tumor genetics

June 15, 2017 | By Rachel Tompa / Fred Hutch News Service

Aspirin and other NSAIDs are linked to decreased mortality in colorectal cancer survivors, a new study finds -- but just for those with the most common tumor subtype.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

June 8, 2017

Fred Hutch epidemiologist Dr. Margaret Madeleine just received a five-year, $2.5 million grant from the National Cancer Institute to test whether the preventive HPV vaccine could be also be used as a therapy anogenital precancers.

View story >


Experimental drug makes some pancreatic cancers more vulnerable to chemo

Early trial shows possibility of knocking down a ‘daunting’ cancer’s defense

June 4, 2017 | by Susan Keown / Fred Hutch News Service

An experimental drug that helps chemo penetrate pancreatic tumors lengthened progression-free survival in a Phase 2 trial.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

May 25, 2017

A team of Fred Hutch researchers led by principal investigator Dr. Eric Holland has received $400,000 for a two-year pilot study to test several novel immunotherapy approaches for glioma, an aggressive brain cancer. The study was made possible by the generous support of the Bezos family, which since 2009 has donated and leveraged more than $40 million to Fred Hutch for immunotherapy research.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.